Register
Question 1
Which provision describes the Securing America's Critical Minerals Supply Chain Act?
Correct Answer:
It would provide a 10% tax deduction for domestically produced pharmaceutical raw ingredients.
Explanation:
The key idea is ensuring a reliable supply of essential minerals by creating a strategic reserve. Critical minerals power defense tech, electronics, and energy storage, and their supply is often concentrated in a small number of countries. A provision that would have the Department of Defense stockpile these minerals provides a buffer that can be drawn on during shortages or market disruptions, helping to stabilize availability and prices for national security and critical industries. The other options don’t directly address securing the mineral supply chain. A tax deduction for domestically produced pharmaceutical raw ingredients boosts domestic production in general, not the resilience of mineral supply. Requiring federal agencies to buy only US-made drugs targets pharmaceutical procurement, not mineral criticality. A public-private research consortium for vaccines centers on vaccine development, not mineral security. So, the provision about stockpiling critical minerals is the best fit for securing America’s critical minerals supply chain.
Question 2
Which of the following is a type of distributor in the pharmaceutical supply chain?
Correct Answer:
Traditional distributors
Explanation:
In the pharmaceutical supply chain, distributors act as the middlemen who move products from manufacturers to pharmacies, hospitals, and other customers. Traditional distributors fit this role as standard wholesale partners: they purchase medicines in large quantities, store them in warehouses, manage inventory, and handle the distribution and logistics that get products to points of care. They provide the established path for most pharmaceutical products to flow from makers to patients. Biotech innovators are the developers of new therapies, not distributors, so they aren’t the distribution channel. Direct-to-consumer wholesalers isn’t a recognized category in pharma; manufacturers may sell directly to consumers in some cases, but that bypasses wholesalers and isn’t a distributor type. Medical device distributors focus on devices rather than pharmaceuticals, so they aren’t the type that handles drug products in the typical supply chain.
Question 3
Which item is NOT included in a New Drug Application (NDA) submission?
Correct Answer:
Market potential forecasts
Explanation:
Market potential forecasts are not part of an NDA submission because the regulatory review focuses on safety, efficacy, and product quality, along with information that affects labeling and patent status. The FDA needs proposed labeling to ensure the approved use, dosing, warnings, and adverse events are clearly communicated. Safety updates are included to provide the latest data on risks and benefits, which can influence labeling and the overall risk–benefit assessment. Patent information is also included to disclose the status of patents and exclusivity that can affect market protection and regulatory timing. In short, the NDA package centers on safety, efficacy, labeling, manufacturing, and patent/exclusivity considerations; market potential forecasts fall outside this regulatory scope.
Question 4
What term describes when a patient brings a prescription from home to be used in a hospital setting?
Correct Answer:
Brown Bagging
Explanation:
Brown-bagging is the practice where a patient brings their own prescribed medications from home to be used during a hospital stay. This term fits perfectly because the scenario centers on patient-provided meds carried into the hospital for administration, often in a brown paper bag. It’s distinct from other terms: cross-docking refers to a logistics technique for moving goods with minimal storage, push ordering is a method of inventory replenishment, and secondary dispensing describes dispensing meds to another setting or party, not the patient’s own medications. In a hospital, this practice raises safety and reconciliation concerns, which is why it’s a well-known term in medication management.
Question 5
What should pharmacy staff do to verify the validity of each transaction when receiving DSCSA products?
Correct Answer:
Review the T3 documents, verify trading partners, and physically inspect the product
Explanation:
DSCSA requires that receiving teams verify each transaction by checking the data that travels with the product, confirming the partner you’re buying from is legitimate, and ensuring the physical product matches what you’re expecting. Reviewing the Transaction Information, History, and Statement (T3) ensures the product’s documented journey and that the information accompanying the shipment is accurate and complete. Verifying trading partners helps confirm you’re dealing with authorized distributors, reducing the risk of counterfeit or diverted product. Physically inspecting the product—checking the packaging, barcodes, lot number, and expiration date—helps detect tampering or mismatches between the data and the actual product. These steps together validate the transaction and the product itself. Merely inspecting packaging color, ignoring the TIH data, or contacting the manufacturer about price do not address the required verification of the transaction and product authenticity.
Question 1
Exam overview

About this Exam

Prepare with the PTCB Supply Chain and Inventory Management Practice Test practice quiz. This question bank includes 10 questions covering describes, supply, chain, distributor, and pharmaceutical. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.

More details

Additional Information

PTCB Supply Chain and Inventory Management Practice Test

This practice set contains 10 questions from the matching question bank and focuses on describes, supply, chain, distributor, and pharmaceutical. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.

This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions

Aquatic Pest Management & Aquatic Science Practice Exam

0 min

Aquatic Pest Management Practice Exam

0 min

Arby's Management Practice Exam Prep

0 min

92Y Supply Active Guard Reserve (AGR) Practice Exam

0 min

Arizona Property Management Practice Exam

0 min

A1 Field Crops Pest Management Practice Exam

0 min